UKBizDB.co.uk

SF PHARMA LIMITED

PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)

This company is commonly known as Sf Pharma Limited. The company was founded 8 years ago and was given the registration number 10037762. The firm's registered office is in ATHERSTONE. You can find them at 7 Brick Kiln Lane, , Atherstone, Warwickshire. This company's SIC code is 46460 - Wholesale of pharmaceutical goods.

Company Information

Name:SF PHARMA LIMITED
Company Number:10037762
Company Type:PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Status:Active
Incorporation Date:02 March 2016
End of financial year:31 March 2023
Jurisdiction:England - Wales
Industry Codes:
  • 46460 - Wholesale of pharmaceutical goods

Office Address & Contact

Registered Address:7 Brick Kiln Lane, Atherstone, Warwickshire, England, CV9 2LU
Country Origin:ENGLAND
Telephone:Unreported
Email Address:Unreported
Website:Unreported
Social:Unreported

Company Officers

Personal InformationRoleAppointedStatus
7 Brick Kiln Lane, Hurley, Atherstone, United Kingdom, CV9 2LU

Secretary02 March 2016Active
79 - 81, Collingwood Drive, Birmingham, United Kingdom, B43 7JW

Director02 March 2016Active
7 Brick Kiln Lane, Hurley, Atherstone, United Kingdom, CV9 2LU

Director02 March 2016Active
7 Brick Kiln Lane, Hurley, Atherstone, United Kingdom, CV9 2LU

Director02 March 2016Active

People with Significant Control

Mr Fadel Takrouri
Notified on:06 April 2016
Status:Active
Date of birth:July 1960
Nationality:British
Country of residence:England
Address:7, Brick Kiln Lane, Atherstone, England, CV9 2LU
Nature of control:
  • Ownership of shares 25 to 50 percent
  • Voting rights 25 to 50 percent

Account Documents

Accounts

  • Last accounts submitted for period 31 March 2023 (1 year ago)
  • Accounts type was MICRO
  • Next accounts dated 31 March 2024
  • Due by 31 December 2024 (2 months remaining)

Confirmation Statement

  • Last submitted on 14 October 2023 (11 months ago)
  • Next confirmation dated 14 October 2024
  • Due by 28 October 2024 (0 months remaining)

Copyright © 2024. All rights reserved.